Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aramine
2. Araminol
3. Bitartrate, Metaraminol
4. Hydroxyphenylpropanolamine
5. Isophenylephrine
6. M Hydroxynorephedrine
7. M Hydroxyphenylpropanolamine
8. M-hydroxynorephedrine
9. M-hydroxyphenylpropanolamine
10. Meta Hydroxynorephedrine
11. Meta-hydroxynorephedrine
12. Metaradrin
13. Metaraminol
14. Metaraminol Bitartrate
15. Metaraminol Bitartrate (1:1)
16. Metaraminol Tartrate
17. Tartrate, Metaraminol
1. Metaraminol Bitartrate
2. 33402-03-8
3. 3-[(1r,2s)-2-amino-1-hydroxypropyl]phenol;2,3-dihydroxybutanedioic Acid
4. Metaradrine Bitartrate
5. Prestwick_592
6. Prestwick0_000197
7. Prestwick1_000197
8. Prestwick2_000197
9. Mls004712030
10. Spbio_002074
11. Schembl5564262
12. Chembl2062262
13. Amy19471
14. 3-[(1r,2s)-2-amino-1-hydroxypropyl]phenol; 2,3-dihydroxybutanedioic Acid
15. Smr003475005
16. A821761
17. Sr-01000939828
18. Sr-01000939828-2
19. 3-[(1r,2s)-2-azanyl-1-oxidanyl-propyl]phenol; 2,3-bis(oxidanyl)butanedioic Acid
| Molecular Weight | 317.29 g/mol |
|---|---|
| Molecular Formula | C13H19NO8 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 317.11106656 g/mol |
| Monoisotopic Mass | 317.11106656 g/mol |
| Topological Polar Surface Area | 182 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 274 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
Adrenergic alpha-1 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Agonists.)
ABOUT THIS PAGE
49
PharmaCompass offers a list of Metaradrine Bitartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metaradrine Bitartrate manufacturer or Metaradrine Bitartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metaradrine Bitartrate manufacturer or Metaradrine Bitartrate supplier.
PharmaCompass also assists you with knowing the Metaradrine Bitartrate API Price utilized in the formulation of products. Metaradrine Bitartrate API Price is not always fixed or binding as the Metaradrine Bitartrate Price is obtained through a variety of data sources. The Metaradrine Bitartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metaradrine Bitartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metaradrine Bitartrate, including repackagers and relabelers. The FDA regulates Metaradrine Bitartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metaradrine Bitartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Metaradrine Bitartrate supplier is an individual or a company that provides Metaradrine Bitartrate active pharmaceutical ingredient (API) or Metaradrine Bitartrate finished formulations upon request. The Metaradrine Bitartrate suppliers may include Metaradrine Bitartrate API manufacturers, exporters, distributors and traders.
Metaradrine Bitartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metaradrine Bitartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metaradrine Bitartrate GMP manufacturer or Metaradrine Bitartrate GMP API supplier for your needs.
A Metaradrine Bitartrate CoA (Certificate of Analysis) is a formal document that attests to Metaradrine Bitartrate's compliance with Metaradrine Bitartrate specifications and serves as a tool for batch-level quality control.
Metaradrine Bitartrate CoA mostly includes findings from lab analyses of a specific batch. For each Metaradrine Bitartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metaradrine Bitartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Metaradrine Bitartrate EP), Metaradrine Bitartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metaradrine Bitartrate USP).
